Observational studyJapanese journal of clinical oncology2023

Observational study to predict the efficacy and optimal duration of nivolumab treatment in patients with previously treated advanced or recurrent non-small cell lung cancer.

Yasushi Goto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.